pharmacodynamics

(redirected from pharmacodynamic)
Also found in: Dictionary, Medical, Acronyms.

Related to pharmacodynamic: pharmacokinetic

pharmacodynamics

[¦fär·mə·kō·dī′nam·iks]

(pharmacology)

The science that deals with the actions of drugs.

Mentioned in ?

References in periodicals archive ?

Pharmacodynamic pDDIs were further classified as: (a) synergistic or (b) antagonistic.

Study of potential drug-drug interaction between prescribed drugs in patients attending outpatient department of medicine at tertiary-care hospital in south Gujarat region

The study concluded that there was no clinically significant pharmacokinetic or pharmacodynamic interaction between echinacea or policosanol and warfarin in healthy male subjects.

Echinacea policosanol and warfarin

Clinical studies in humans and research using animal brains will lag years--maybe decades--behind theory because of the complexity of pharmacodynamic interactions.

More innovation needed

The FDA advised health care professionals to counsel patients taking immediate-release low-dose (81 mg) aspirin (not enteric coated) and 400 mg of ibuprofen to take the ibuprofen at least 8 hours before or at least 30 minutes after taking the aspirin, which can minimize the pharmacodynamic interaction.

Alert issued on low-dose aspirin + ibuprofen

In addition, the safety, pharmacodynamic and pharmacokinetic data from the two studies will inform the design of a subsequent Phase 2 proof of concept study in neuropathic pain, concluded the company.

Relmada Therapeutics to begin first pharmacokinetic and pharmacodynamic study of d-Methadone for neuropathic pain in Canada

Ciprofloxacin has pharmacodynamic potency against aeruginosa, a track record of safety in large populations, and a large published literature.

Quinolone safety and efficacy more important than potency

To do that, the research team used control and drug-treated tumor cells, together with samples from healthy volunteers for comparison, to develop quantitative multiplex immunofluorescent assays that measure target-specific pharmacodynamic biomarkers for EP in CTCs that were isolated pre- and post-treatment.

CTC-based biomarkers can be assessed for sensitivity to Nektar's etirinotecan pegol for breast cancer - report

The study is expected to evaluate the safety, tolerability, pharmacokinetic and pharmacodynamic profile of BGB324.

BerGenBio starts phase 1 trial of BGB324

pneumoniae should not be limited to MICs alone because pharmacokinetic and pharmacodynamic characteristics differ for each fluoroquinolone.